CD34 and acute myeloid leukemia: It has been shown that Nrf2 and miR-125B1 are increased in AML in comparison with normal CD34+ hematopoietic stem cells (HSC), while miR-29B1 is reduced in AML compared with normal CG34+ HSC [48].